“$3 Billion Exit”

The right Chief People Officer doesn’t manage HR — they architect the talent systems that create enterprise value.

BioAgilytix, a CRO specializing in bioanalytical testing for pharmaceutical companies, was experiencing explosive growth under GHO Capital ownership. The CEO knew that culture and talent would either fuel the next phase of growth or kill it. GHO was building toward a major exit, and they couldn’t afford a talent crisis derailing valuation.

They needed a Chief People Officer who had scaled life sciences companies through rapid growth and positioned them for exits.

Within 18 months of Canopy filling this position:

• Turnover dropped 25%

• Employee engagement scores climbed into the top quartile for life sciences

• Leadership bench deepened with internal promotions

• Culture became a competitive advantage in recruiting top scientific talent

The Outcome

Cinven acquired BioAgilytix for $3.2 billion. In the deal prospectus, buyers specifically cited the company’s strong culture, employee retention, deep leadership bench, and scalable talent systems.